Resonant Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Resonant Capital Advisors's VRTX Position: Q2 2026 in Review
Resonant Capital Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 2.8% in Q2 2026, selling an estimated $22.2K and leaving 1,726 shares worth $857K. The position accounts for 0.04% of the portfolio, ranked #208.
Resonant Capital Advisors first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Resonant Capital Advisors held 1,726 shares of Vertex Pharmaceuticals worth $857K as of Q2 2026.
- Resonant Capital Advisors sold 50 Vertex Pharmaceuticals shares in Q2 2026, an estimated $22.2K.
- Vertex Pharmaceuticals made up 0.04% of Resonant Capital Advisors's portfolio in Q2 2026, its #208 holding.
- Resonant Capital Advisors first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.